Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pediatric Crohn's disease × Methotrexate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 213 Leukemia 163 Lymphoma 120 Leukemia, Myeloid, Acute 88 Burkitt Lymphoma 78 Myelodysplastic Syndromes 68 Breast Neoplasms 57 Lymphoma, Non-Hodgkin 56 Lymphoma, Large B-Cell, Diffuse 52 Lymphoma, Mantle-Cell 42 Graft vs Host Disease 42 Leukemia, Lymphocytic, Chronic, B-Cell 41 Lymphoma, Follicular 39 Hodgkin Disease 39 Leukemia, Myeloid, Accelerated Phase 37 Leukemia, Myeloid, Chronic-Phase 32 Multiple Myeloma 31 Leukemia, Myelomonocytic, Chronic 31 Blast Crisis 31 Congenital Abnormalities 30 Recurrence 29 Myeloproliferative Disorders 29 Lymphoma, Large-Cell, Immunoblastic 28 Leukemia, Biphenotypic, Acute 28 Osteosarcoma 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 26 Lymphoma, B-Cell, Marginal Zone 26 Dendritic Cell Sarcoma, Interdigitating 23 Primary Myelofibrosis 22 Neoplasms, Plasma Cell 21

Interventions

Sugars 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02772965 2023-04-12

COMBINE

University of North Carolina, Chapel Hill

Phase 3 Completed

306 enrolled 16 charts

Pediatric Crohn's disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡